Bright Minds Biosciences Statistics
Total Valuation
DRUG has a market cap or net worth of $299.53 million. The enterprise value is $262.53 million.
Important Dates
The last earnings date was Monday, August 11, 2025, before market open.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DRUG has 7.08 million shares outstanding. The number of shares has increased by 49.67% in one year.
Current Share Class | 7.08M |
Shares Outstanding | 7.08M |
Shares Change (YoY) | +49.67% |
Shares Change (QoQ) | +0.65% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 3.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 7.88 |
P/TBV Ratio | 7.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 86.56, with a Debt / Equity ratio of 0.00.
Current Ratio | 86.56 |
Quick Ratio | 85.39 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -962.44 |
Financial Efficiency
Return on equity (ROE) is -30.79% and return on invested capital (ROIC) is -18.53%.
Return on Equity (ROE) | -30.79% |
Return on Assets (ROA) | -18.31% |
Return on Invested Capital (ROIC) | -18.53% |
Return on Capital Employed (ROCE) | -16.59% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4,167.96% in the last 52 weeks. The beta is 0.17, so DRUG's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | +4,167.96% |
50-Day Moving Average | 31.69 |
200-Day Moving Average | 34.72 |
Relative Strength Index (RSI) | 69.20 |
Average Volume (20 Days) | 53,025 |
Short Selling Information
The latest short interest is 203,749, so 2.88% of the outstanding shares have been sold short.
Short Interest | 203,749 |
Short Previous Month | 169,044 |
Short % of Shares Out | 2.88% |
Short % of Float | 6.78% |
Short Ratio (days to cover) | 5.21 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.31M |
Pretax Income | -3.82M |
Net Income | -6.54M |
EBITDA | n/a |
EBIT | -6.31M |
Earnings Per Share (EPS) | -$1.06 |
Full Income Statement Balance Sheet
The company has $37.68 million in cash and $103,405 in debt, giving a net cash position of $37.57 million or $5.30 per share.
Cash & Cash Equivalents | 37.68M |
Total Debt | 103,405 |
Net Cash | 37.57M |
Net Cash Per Share | $5.30 |
Equity (Book Value) | 38.00M |
Book Value Per Share | 5.36 |
Working Capital | 37.95M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -5.78M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DRUG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -49.67% |
Shareholder Yield | -49.67% |
Earnings Yield | -2.18% |
FCF Yield | n/a |
Analyst Forecast
The average price target for DRUG is $83.60, which is 90.17% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $83.60 |
Price Target Difference | 90.17% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 14, 2023. It was a reverse split with a ratio of 1:5.
Last Split Date | Jul 14, 2023 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |